These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27907063)

  • 1. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
    Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
    PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
    Sanuki N; Takeda A; Oku Y; Eriguchi T; Nishimura S; Aoki Y; Mizuno T; Iwabuchi S; Kunieda E
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):306-11. PubMed ID: 24411601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced Liver Injury after 3D-conformal Radiotherapy for Hepatocellular Carcinoma: Quantitative Assessment Using Gd-EOB-DTPA-enhanced MRI.
    Fukugawa Y; Namimoto T; Toya R; Saito T; Yuki H; Matsuyama T; Ikeda O; Yamashita Y; Oya N
    Acta Med Okayama; 2017 Feb; 71(1):25-29. PubMed ID: 28238007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
    Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images.
    Jung SH; Yu JI; Park HC; Lim DH; Han Y
    Radiat Oncol J; 2016 Mar; 34(1):64-75. PubMed ID: 27104169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
    Jung J; Kim H; Yoon SM; Cho B; Kim YJ; Kwak J; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):867-874. PubMed ID: 29934276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Li J; Wang J; Lei L; Yuan G; He S
    Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume change and liver parenchymal signal intensity in Gd-EOB-DTPA-enhanced magnetic resonance imaging after portal vein embolization prior to hepatectomy.
    Akiba A; Murata S; Mine T; Onozawa S; Sekine T; Amano Y; Kawano Y; Uchida E; Kumita S
    Biomed Res Int; 2014; 2014():684754. PubMed ID: 25302304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
    Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
    Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.
    Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K
    J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma.
    Bekki Y; Mahamid A; Lewis S; Ward SC; Simpson W; Argiriadi P; Kamath A; Facciuto L; Patel RS; Kim E; Schiano TD; Facciuto ME
    HPB (Oxford); 2022 Dec; 24(12):2185-2192. PubMed ID: 36085263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.